James Krainson, M.D. – FDA Inspection, Sep 22, 2021

Record Details

This FDA Inspection record concerns James Krainson, M.D., with an inspection on September 22, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: James Krainson, M.D.
Inspection Date: September 22, 2021
Product Type: Drugs
Office: Center for Drug Evaluation and Research

View Company Profile

ID · 3e4b1b0f-ff9a-48b3-b8be-fa6d5feccfab

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1152348
FDA center: Human Drugs
Project area: Bioresearch Monitoring

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore James Krainson, M.D.

FDA Inspection

James Krainson, M.D.September 22, 2021